European Journal of Clinical Pharmacology 2008-01-01

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.

Mária Tóth, Sándor Drabant, Bálint Varga, Gyula Végso, Anna Cseh, Imre Szentpéteri, Imre Klebovich

Index: Eur. J. Clin. Pharmacol. 64(1) , 93-4, (2008)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Tofisopam CAS:22345-47-7	C₁₈H₃₉N₅O₁₃S

The atypical anxiolytic drug, tofisopam, selectively blocks ...
2010-11-01
[J. Neural Transm. Gen. Sect. 117(11) , 1319-25, (2010)]

[Pineal hormone melatonin in low doses potentiates psychotro...
2013-01-01
[Eksp. Klin. Farmakol. 76(4) , 15-7, (2013)]

Clinical trial: dextofisopam in the treatment of patients wi...
2008-01-15
[Aliment. Pharmacol. Ther. 27(2) , 197-206, (2008)]

Various effects of antidepressant drugs on bone microarchite...
2007-05-15
[Toxicol. Appl. Pharmacol. 221(1) , 111-8, (2007)]

Method validation and determination of enantiomers and confo...
2006-09-29
[J. Chromatogr. A. 1129(1) , 47-53, (2006)]